Genomic Pioneer Craig Venter Steps Down as CEO at HLI

2017 ◽  
Vol 4 (1) ◽  
pp. 42-43
Keyword(s):  
2009 ◽  
Vol 203 (2718) ◽  
pp. 25 ◽  
Author(s):  
Catherine Brahic
Keyword(s):  

2019 ◽  
Vol 41 (3) ◽  
pp. 6-9 ◽  
Author(s):  
Tom Ellis

You may have heard of synthetic genomics. This headline-grabbing, high-profile, big science topic is starting to emerge catalysed by the pioneering work of famous names in synthetic biology and biotechnology like George Church and Craig Venter. But what is synthetic genomics and what is it being used for? As a prominent researcher at a recent UK meeting said: “Is it just synthetic biology with bigger bits of DNA?” Well no, not quite…


2016 ◽  
pp. 219-234
Author(s):  
Balmer Andrew ◽  
Herreman Camille
Keyword(s):  

2000 ◽  
Vol 28 (2) ◽  
pp. 188-189
Author(s):  
Jennifer Doran

On April 6, 2000, Dr. J. Craig Venter of Celera Genomics told a Congressional committee that his company finished its analysis of the human DNA and would have a completed map of the human genome by early summer, 2000. Scientists expect the completed human genome to revolutionize drug therapies through the creation of treatments tailored to specific genetic makeups. In order to create a map of the human genome, three billion letters of DNA that encode eighty thousand genes must be identified and ordered. In March, 2000, Celera released a successful sequence of the fruit fly genome, and it employed the same methods in creating the human genome.


2007 ◽  
Vol 196 (2626) ◽  
pp. 56-57
Author(s):  
Peter Aldhous
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document